Zhejiang Jianfeng Group Company Ltd (600668):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Zhejiang Jianfeng Group Company Ltd (600668) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9302
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zhejiang Jianfeng Group Company Ltd (Jianfeng) is a diversified company. The company operates in the business of manufacturing cement, pharmaceuticals, health products, telecommunication and cables. It offers cement products that includes composite, ordinary, and slag Portland cement products. Jianfeng’s pharmaceutical products includes aspartic acid amlodipine tablets for hypertension; paroxetine hydrochloride tablets for various types of anxieties related with depression; vinegar acid chloride Finn zyban products for symptoms caused by osteoarthritis and rheumatoid arthritis; spray vial products for severe herpes zoster patients; sodium hyaluronate eye drops for dry eyes; and others. Jianfeng’s offers cable products comprising BV line common insulated and household electric wires; HYA series, which are copper core, solid polyolefin insulation block, and communications cables; RVV series that are cable mains; and SYWV-75 series products that are physical foaming cables. The company offers health products such as boiling Jade Kim tea bags, grape seed extract soft capsules, bomb sugar, Tianfu capsules, vitamin E nutritional capsules, bone Thai capsules, goodnight capsules, Sangge tea, lyophilized Tianma pieces, and broken fungus spore powder. It also offers warehousing and logistics services. Jianfeng is headquartered in Jinhua, China.

Zhejiang Jianfeng Group Company Ltd (600668) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Zhejiang Jianfeng To Form Joint Venture With Shanghai-Based Biotechnology Company 10
Debt Offering 11
Zhejiang Jianfeng to Raise USD48.8 Million in Second Tranche of Private Placement of Bonds 11
Zhejiang Jianfeng Group Completes Private Placement Of Notes Due 2013 For US$32 Million 12
Acquisition 13
Zhejiang Jianfeng Plans to Acquire 50.7% Stake in China-Based Biotech Company 13
Zhejiang Jianfeng to Acquire 95% Stake in Nexchem Pharma 14
Zhejiang Jianfeng Group Company Ltd – Key Competitors 15
Zhejiang Jianfeng Group Company Ltd – Key Employees 16
Zhejiang Jianfeng Group Company Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Zhejiang Jianfeng To Form Joint Venture With Shanghai-Based Biotechnology Company 10
Zhejiang Jianfeng to Raise USD48.8 Million in Second Tranche of Private Placement of Bonds 11
Zhejiang Jianfeng Group Completes Private Placement Of Notes Due 2013 For US$32 Million 12
Zhejiang Jianfeng Plans to Acquire 50.7% Stake in China-Based Biotech Company 13
Zhejiang Jianfeng to Acquire 95% Stake in Nexchem Pharma 14
Zhejiang Jianfeng Group Company Ltd, Key Competitors 15
Zhejiang Jianfeng Group Company Ltd, Key Employees 16
Zhejiang Jianfeng Group Company Ltd, Subsidiaries 17

List of Figures
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Zhejiang Jianfeng Group Company Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Zhejiang Jianfeng Group Company Ltd (600668):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SDL plc (SDL):企業の財務・戦略的SWOT分析
    Summary SDL Plc (SDL) is a technology solution provider that offers language translation technology, services, and content management services. The company’s products include live content architect, live content create, media manager, idiom world server, campaign analytics, email manager, language w …
  • HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析
    HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Theravectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Theravectys SA (TheraVectys) is a clinical development biotech company that develops new generation therapeutic vaccines and immunotherapies. The company develops viral vectors vaccines to support body and prepare against future infections by pre-exposing immune system to partial, dead, inac …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Ra Medical Systems Inc (RMED):企業の製品パイプライン分析
    Summary Ra Medical Systems Inc (Ra Medical Systems) is a medical device company that develops, designs, and commercializes excimer laser systems for the treatment of cardiovascular and dermatologic diseases. The company’s technology provides operational versatility and dose customization. Its produc …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • Tanzania Electric Supply Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Tanzania Electric Supply Co Ltd (TANESCO), formerly Tanganyika Electric Supply Co Ltd, is a government-owned integrated power company. The company’s operations are regulated by the Ministry of Energy and Minerals. It generates, transmits, distributes and supplies electricity. TANESCO generat …
  • Nynas AB:企業の戦略的SWOT分析
    Nynas AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Cushman & Wakefield Inc:企業のM&A・事業提携・投資動向
    Cushman & Wakefield Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cushman & Wakefield Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Bostwick Laboratories Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bostwick Laboratories Inc (Bostwick) is a medical laboratory that focuses on the interpretation of prostate and urological biopsies. The company offers services such as client services, clinical services, urologic laboratory services, and subspecialty laboratory services. Its urologic labora …
  • Kronos Worldwide Inc (KRO):企業の財務・戦略的SWOT分析
    Kronos Worldwide Inc (KRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Mironid Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mironid Ltd (Mironid) is a drug discovery company that develops drug candidate molecules. The company offers drug candidate by modulating the activity of key cell signaling proteins for the treatment of degenerative kidney diseases, chronic inflammatory diseases, and cancer. Its drug discove …
  • BOOM Logistics Ltd (BOL):企業の財務・戦略的SWOT分析
    BOOM Logistics Ltd (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nitto Denko Corp (6988):製薬・医療:M&Aディール及び事業提携情報
    Summary Nitto Denko Corp (Nitto) is a manufacturer of diversified material, which produces electrical insulating material, electronics, industrial and functional products by harnessing its core technologies such as polymer synthesis, and adhesive and coating technologies. The company offers a broad …
  • International Games System Co Ltd:企業の戦略・SWOT・財務分析
    International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report Summary International Games System Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • TRC Companies Inc:電力:M&Aディール及び事業提携情報
    Summary TRC Companies Inc (TRC Companies) is a construction service provider that offers engineering, consulting and construction management. The company’s services include air quality management, power generation, power delivery engineering, integrity management, energy efficiency, coal ash managem …
  • British Columbia Ferry Services Inc.:企業の戦略的SWOT分析
    British Columbia Ferry Services Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • RedHill Biopharma Ltd (RDHL):企業の財務・戦略的SWOT分析
    RedHill Biopharma Ltd (RDHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆